Cerebrolysin demonstrates superior performance in acute ischemic stroke models, with Phase IV clinical trials showing measurable cognitive improvements at 30ml daily IV for 21 days in post-stroke patients, and rodent MCAO (middle cerebral artery occlusion) studies documenting 1825% reductions in infarct volume
This research blend combines BPC 157 & TB500 into a single formulation designed for advanced laboratory investigation of cellular repair signalling tissue organisation and intracellular communication pathways
Yue Q, Wang Z, Shen Y, Lan Y, Zhong X, Luo X, et al
Once the tip of the needle and cannula are placed, the cannula is advanced inside the vein over the trocar to the appropriate position and secured
Depending on your results, your healthcare professional will recommend an appropriate dosage
Individual responses can vary, and not everyone might notice improvements in muscle recovery or immune function